143 related articles for article (PubMed ID: 30091418)
1. Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review.
Hussain H; Csuk R; Green IR; Ur Rehman N; Abbas G; Hussain W
Recent Pat Anticancer Drug Discov; 2018; 13(4):411-421. PubMed ID: 30091418
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in the Chemistry and Therapeutic Evaluation of Naturally Occurring and Synthetic Withanolides.
Singh A; Raza A; Amin S; Damodaran C; Sharma AK
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164150
[TBL] [Abstract][Full Text] [Related]
3. Patent Survey of Resveratrol, Taxol, Podophyllotoxin, Withanolides and Their Derivatives Used in Anticancer Therapy.
Routh S; Nandagopal K
Recent Pat Biotechnol; 2017; 11(2):85-100. PubMed ID: 28137207
[TBL] [Abstract][Full Text] [Related]
4. Natural Withanolides in the Treatment of Chronic Diseases.
White PT; Subramanian C; Motiwala HF; Cohen MS
Adv Exp Med Biol; 2016; 928():329-373. PubMed ID: 27671823
[TBL] [Abstract][Full Text] [Related]
5. Withanolides: Promising candidates for cancer therapy.
Zhang Q; Yuan Y; Cao S; Kang N; Qiu F
Phytother Res; 2024 Feb; 38(2):1104-1158. PubMed ID: 38176694
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of glycyrrhetinic acids: a patent review (2010-2017).
Hussain H; Green IR; Shamraiz U; Saleem M; Badshah A; Abbas G; Rehman NU; Irshad M
Expert Opin Ther Pat; 2018 May; 28(5):383-398. PubMed ID: 29558289
[TBL] [Abstract][Full Text] [Related]
7. Ursolic acid derivatives for pharmaceutical use: a patent review (2012-2016).
Hussain H; Green IR; Ali I; Khan IA; Ali Z; Al-Sadi AM; Ahmed I
Expert Opin Ther Pat; 2017 Sep; 27(9):1061-1072. PubMed ID: 28637397
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacins as Anticancer Agents: A Patent Review.
Hussain H; Green IR; Saleem M; Khattak KF; Irshad M; Ali M
Recent Pat Anticancer Drug Discov; 2019; 14(2):133-143. PubMed ID: 30451116
[TBL] [Abstract][Full Text] [Related]
9. Withaferin A and its potential role in glioblastoma (GBM).
Dhami J; Chang E; Gambhir SS
J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of boswellic acids: a patent review (1990-2015).
Hussain H; Al-Harrasi A; Csuk R; Shamraiz U; Green IR; Ahmed I; Khan IA; Ali Z
Expert Opin Ther Pat; 2017 Jan; 27(1):81-90. PubMed ID: 27646163
[TBL] [Abstract][Full Text] [Related]
11. Withanolides from the genus Physalis: a review on their phytochemical and pharmacological aspects.
Huang M; He JX; Hu HX; Zhang K; Wang XN; Zhao BB; Lou HX; Ren DM; Shen T
J Pharm Pharmacol; 2020 May; 72(5):649-669. PubMed ID: 31826333
[TBL] [Abstract][Full Text] [Related]
12. Natural Bioactive New Withanolides.
Xu QQ; Wang KW
Mini Rev Med Chem; 2020; 20(12):1101-1117. PubMed ID: 29189150
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer.
Yadav DK; Kumar S; Saloni ; Singh H; Kim MH; Sharma P; Misra S; Khan F
Drug Des Devel Ther; 2017; 11():1859-1870. PubMed ID: 28694686
[TBL] [Abstract][Full Text] [Related]
14. Potential Anticancer Properties and Mechanisms of Action of Withanolides.
Samadi AK
Enzymes; 2015; 37():73-94. PubMed ID: 26298456
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic taccalonolides and withanolides from Tacca chantrieri.
Ni G; Yang HZ; Fu NJ; Zhang LL; Wang MC; Chen J; Zhang CL; Li Y; Chen XG; Chen RY; Yu DQ
Planta Med; 2015 Feb; 81(3):247-56. PubMed ID: 25679147
[TBL] [Abstract][Full Text] [Related]
16. Three new withanolides from the calyces of Nicandra physaloides.
Xiao Q; Wang CF; Chen J; Lian CL; Xu Y; Xiao L; Liu JQ
Steroids; 2018 Mar; 131():32-36. PubMed ID: 29355564
[TBL] [Abstract][Full Text] [Related]
17. Withaferin A and Withanolide D Analogues with Dual Heat-Shock-Inducing and Cytotoxic Activities: Semisynthesis and Biological Evaluation.
Wijeratne EMK; Oliveira MCF; Mafezoli J; Xu YM; Minguzzi S; Batista PHJ; Pessoa ODL; Whitesell L; Gunatilaka AAL
J Nat Prod; 2018 Apr; 81(4):825-837. PubMed ID: 29537263
[TBL] [Abstract][Full Text] [Related]
18. Separation and identification of tubocapsanolide MAP and tubocapsunolide A, and the structure-activity relationship of their anti-TNBC activity.
Shou P; Li J; Wei Y; Kai G; Wang F; Zhao H; Yang B
Steroids; 2020 Dec; 164():108734. PubMed ID: 33010265
[TBL] [Abstract][Full Text] [Related]
19. Natural withanolides: an overview.
Chen LX; He H; Qiu F
Nat Prod Rep; 2011 Apr; 28(4):705-40. PubMed ID: 21344104
[TBL] [Abstract][Full Text] [Related]
20. Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.
Lee IC; Choi BY
Int J Mol Sci; 2016 Mar; 17(3):290. PubMed ID: 26959007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
